Chief Scientific Officer
at NextCell Pharma AB
Dr. Lindsay Davies completed her PhD in biochemistry in 2006 at Cardiff University, UK. Focusing on cell therapy for cartilage repair, her thesis work introduced her to cell and gene therapy, springboarding her into a career within the field, starting with a postdoc and two fellowship positions in stem/stromal cell biology within the UK. During this time, Davies discovered a novel stem cell population within the oral cavity, which she patented and won multiple awards related to this work. In 2020, Davies moved into industry, setting up her own consulting company, CellTherEx, to support academics and companies spinning out and handling regulatory compliance within the drug discovery and advanced therapeutic development space. This offered her the opportunity to join NextCell Pharma, a cell therapy company developing stromal cell products for use in multiple clinical indications. As their chief scientific officer, she has supported the company´s movement from a Phase 1 company, with one initial clinical trial, to five active Phase 1/2 trials, international expansion and a Phase 3 in development. In 2024, Davies co-founded QVance, a subsidiary of NextCell Pharma, specialising in quality control analytics service provision for advanced therapy developers. The company was launched in November 2024 and aims to be a “one-stop shop” analytics company serving the Nordics and wider Europe. Davies continues to work closely with academia in the space of wound healing and cell therapy development. In addition to her academic and industrial roles, Davies is vice president elect for Europe at the ISCT, sitting on the European Task Force and several committees related to process development and commercialization, as well as the inaugural chair for ISCT’s European Industry committee. She is also an industry representative for the Swedish national ATMP coordinating team and a member of a number of Boards for European societies and corporate entities.
Education
Awards & Certifications
Certification in Auditing for Pharmaceuticals and Medical Devices, 2021
Certification in Good Clinical Practice, 2019
Certification in Good Manufacturing Practice for Advanced Therapeutic Medicinal Products, 2019
Certification in Leading and Management, 2013
Accreditations
Vice President Elect Europe recognised by the International Society for Cell and Gene Therapy
Founding Chair of the European Industry Committee recognised by the International Society of Cell and Gene Therapy
Board of Directors recognised by ATMP Sweden
Advisory Board recognised by Phacilitate Europe
Industrial representative recognised by the Swedish National Coordination Group for ATMPs
Member of European Task Force for ATMPs recognised by the International Society for Cell and Gene Therapy
Member recognised by the International Society of Cell and Gene Therapy Particulate Working Group
Member recognised by the International Society of Cell and Gene Therapy Commercialisation Committee
Member recognised by the International Society of Cell and Gene Therapy Process and Product Subcommittee
Areas of Expertise
Got a Question for Lindsay Davies, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
What Skills Do the Next Generation of Scientists Need?
